Using genetic and clinical factors to predict tacrolimus dose in renal transplant recipients

Tacrolimus Population Pharmacokinetic-Pharmacogenetic Analysis and Bayesian Estimation in Renal Transplant Recipients

(2009) Khaled Benkali et al.   CLINICAL PHARMACOKINETICS

Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in De Novo Pediatric Kidney Transplant Recipients

(2009) W Zhao et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

No impact of age on dose-adjusted pharmacokinetics of tacrolimus, mycophenolic acid and prednisolone 1 month after renal transplantation

(2009) Masatomo Miura et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference

(2009) Pierre Wallemacq et al.   THERAPEUTIC DRUG MONITORING

New Insights Into the Pharmacokinetics and Pharmacodynamics of the Calcineurin Inhibitors and Mycophenolic Acid: Possible Consequences for Therapeutic Drug Monitoring in Solid Organ Transplantation

(2009) Hylke de Jonge et al.   THERAPEUTIC DRUG MONITORING

A Pharmacogenetic Strategy for Immunosuppression Based on the CYP3A5 Genotype

(2009) Iain A. M. MacPhee et al.   TRANSPLANTATION

Pharmacogenetics of Calcineurin Inhibitors in Renal Transplantation

(2009) Eliecer Coto et al.   TRANSPLANTATION

Incidence and Risk Factors for Diarrhea Following Kidney Transplantation and Association With Graft Loss and Mortality

(2008) Suphamai Bunnapradist et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Influence ofCYP3A5Genetic Polymorphism on Tacrolimus Daily Dose Requirements and Acute Rejection in Renal Graft Recipients

(2008) Lina Quteineh et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Lack of tacrolimus circadian pharmacokinetics andCYP3A5pharmacogenetics in the early and maintenance stages in Japanese renal transplant recipients

(2008) Shigeru Satoh et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

CYP3A5⁎3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia

(2008) Maria Alice V. Willrich et al.   CLINICA CHIMICA ACTA

CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients

(2008) Dennis A. Hesselink et al.   Pharmacogenetics and Genomics

Clinical Relevance and Prevalence of Polymorphisms in CYP3A5 and MDR1 Genes That Encode Tacrolimus Biotransformation Enzymes in Liver Transplant Recipients

(2008) L. Barrera-Pulido et al.   TRANSPLANTATION PROCEEDINGS